Pharmacogenomics of Pediatric Cardiac Arrest: Cisplatin Treatment Worsened by a Ryanodine Receptor 2 Gene Mutation

Pharmacogenomics of Pediatric Cardiac Arrest: Cisplatin Treatment Worsened by a Ryanodine Receptor 2 Gene Mutation

In thelast few decades, the roles of cardio-oncology and cardiovascular geneticsgained more and more attention in research and daily clinical practice, shaping a new clinical approach and management of patients affected by cancer and cardiovascular disease. Genetic characterization of patients under...

Full description

Bibliographic Details
Main Authors: Angela Maggio, Sandra Mastroianno, Giuseppe Di Stolfo, Stefano Castellana, Pietro Palumbo, Maria Pia Leone, Anita Spirito, Domenico Rosario Potenza, Saverio Ladogana, Marco Castori, Massimo Carella, Massimo Villella, Mauro Pellegrino Salvatori
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cardiogenetics
Subjects:
cardiac arrest
cisplatin
ryanodine receptor 2 gene mutation
pharmacogenomics
neuroblastoma
Online Access:https://www.mdpi.com/2035-8148/12/1/7

Internet

https://www.mdpi.com/2035-8148/12/1/7

Similar Items